Rafael Holdings Inc Sustainability Reports
Rafael Holdings, Inc. operates as a clinical-stage biotechnology company that focuses on developing and commercializing therapeutic treatments. The company's lead asset evaluates treatments for rare, progressive genetic disorders and novel cancer therapies.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: 549300H0TEZ17UNHVR17
FIGI: BBG00J3YYSB9
5 reports from 2019 to 2024